3D printing has been progressing rapid-speed over the past few years, with numerous forays to the next level into 4D printing, whether in serious world-changing endeavors or those that are creative and sometimes even whimsical, such as fashion. Now, researchers see that 4D advancements in bioprinting may trickle down to doctor’s offices too. Authors Pedro Morouço and João Gil of Biofabrication RDi Group, Centre for Rapid and Sustainable Product Development at Polytechnic Institute of Leiria (Portugal) expand on their findings in Four-Dimensional Bioprinting for Regenerative Medicine: Mechanisms to Induce Shape Variation and Potential Applications.
Regenerative medicine is a central focus in bioprinting as researchers around the world try to overcome the challenges of sustaining living tissue in the lab. The end goal, the holy grail of bioprinting, will be to eventually fabricate human organs in the lab—or perhaps even in clinical practice—meaning the elimination of donor lists, organ rejection, and failing quality of life for a multitude of patients globally.
“Regenerative engineering has come to be considered an inevitability and a promising approach for the regeneration of tissues or organs by culturing patient cells into biological substitutes (scaffolds) and subsequent implantation into the patient for the regeneration of new tissue,” state the researchers, pointing out that scaffolds can be made through both conventional and newer techniques—both offering a list of pros and cons.
The team leans toward using 3D printing and venturing into the 4D however, pointing out the potential for greater strides in medicine and tissue regeneration, with so much more control over pore size, shape, and interconnectivity. With 4D printing, researchers can move beyond the restrictions of implants unable to transform according to their biological environment.
“The potential of 3D printing enhanced by a fourth dimension makes it possible to contribute significantly to the bioprinting of engineered tissues, such as the liver and heart, which will represent a major breakthrough in the area of regenerative medicine,” state the researchers.
Bioinks are commonly used in fabricating viable cells, but they must meet certain criteria for success and researchers must navigate fragility to temperature as well as peripheral chemicals, stress, and issues like UV light exposure. Significant progress has been made with ‘smart materials’ also, namely with bioprinting and some level of shape-morphing. And while creating patient-specific organs may seem to be right around the corner, the research team points out that there is still much progress to be made in creating human tissue structures in the lab.
“The interdisciplinary combination of life sciences with engineering is demonstrating noteworthy advances for healthcare,” conclude the researchers. “Although 3D bioprinting has opened minds to biofabrication, the absence of response to planned stimuli should be considered. However, it does provide an appropriate tool to create hybrid, versatile, and functional tissue constructs; thus, coupling biofabrication with stimuli-responsive materials, novel maturation processes, and validation procedures will bring us one step closer to successful regenerative medicine.”
What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.[Source / Images: Four-Dimensional Bioprinting for Regenerative Medicine: Mechanisms to Induce Shape Variation and Potential Applications]
You May Also Like
Trump the Mundane Performance in Smart Printing — Creality CR-10 Smart Vanquishes with Advanced Functions
In an era that 3D printing functions seems to sit in a stereotyped mundane track, how to renovate turns to be of much importance that often draws the attention of...
The Boat Builder, the EinScan H and Fusion 360: Craftsmanship Meets Technology
From the heart of the UK to the sea The Cotswolds, a region located in the heart of the UK is not where one might expect to find a boat...
3D Printing Webinar and Event Roundup: July 10th, 2021
We’ve got another busy week of industry webinars and events, both virtual and in-person, to tell you about! Topics range from automotive 3D printing and 3D printing steel to point-of-care...
Parkway VC Launches $60M Fund Targeting Simulation and AI Startups
Emerging New York investment firm Parkway Venture Capital is raising up to $60 million for its second fund aimed at startups pioneering artificial intelligence (AI) and simulation developments to drive...
View our broad assortment of in house and third party products.